Edition:
United Kingdom

Achillion Pharmaceuticals Inc (ACHN.OQ)

ACHN.OQ on NASDAQ Stock Exchange Global Select Market

3.51USD
21 Sep 2018
Change (% chg)

$-0.03 (-0.85%)
Prev Close
$3.54
Open
$3.51
Day's High
$3.58
Day's Low
$3.38
Volume
2,120,425
Avg. Vol
249,182
52-wk High
$4.81
52-wk Low
$2.35

Chart for

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. The Company is focused on its complement inhibitor platform, directed at advancing small molecule compounds that have the... (more)

Overall

Beta: 1.68
Market Cap(Mil.): $650.99
Shares Outstanding(Mil.): 136.76
Dividend: --
Yield (%): --

Financials

  ACHN.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.50 -- --
ROI: -17.34 1.79 14.61
ROE: -17.36 3.28 16.33

BRIEF-Achillion Pharma Says Truitt Gets Annualized Base Salary Of $560,000

* ACHILLION PHARMACEUTICALS SAYS JOSEPH TRUITT RECEIVES ANNUALIZED BASE SALARY OF $560,000, IN CONNECTION WITH APPOINTMENT AS CEO - SEC FILING

02 May 2018

BRIEF-Achillion Reports Q1 Loss Per Share $0.15

* ACHILLION REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND MANAGEMENT TRANSITION

02 May 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $44.06 +0.31
Johnson & Johnson (JNJ.N) $142.88 +0.90
Novartis AG (NOVN.S) CHF81.88 -0.06
Merck & Co., Inc. (MRK.N) $71.10 +0.32
Roche Holding Ltd. (ROG.S) CHF235.15 +0.10
Roche Holding Ltd. (RO.S) CHF235.40 -1.20
Abbott Laboratories (ABT.N) $69.05 +0.26
AstraZeneca plc (AZN.L) 5,670.00 +98.00
GlaxoSmithKline plc (GSK.L) 1,531.40 +45.60
Bristol-Myers Squibb Co (BMY.N) $62.25 +0.50

Earnings vs. Estimates